Sign in
4

Changes in Ownership

PDS Biotechnology Corp Filed Acc 0001127602-18-000822

Options or other derivatives

  • Chief Medical Officer acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Faleck Herbert J · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-01-02 Grant or award : show line 1 in the form Stock Option (Right To Purchase) +50,000 50,000 D
Loading xslF345X03/form4.xml…